CREO MEDICAL LIMITED
Get an alert when CREO MEDICAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-11-06 (in 6mo)
Last made up 2025-10-23
Watchouts
None on the register
Cash
£3M
+100.3% vs 2023
Net assets
-£161M
-24.6% vs 2023
Employees
139
-7.9% vs 2023
Profit before tax
-£34M
-20.3% vs 2023
Name history
Renamed 1 time since incorporation
- CREO MEDICAL LIMITED 2010-08-10 → present
- MICROONCOLOGY LTD 2003-02-06 → 2010-08-10
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £3,005,000 | £1,479,000 | |
| Operating profit | -£25,142,000 | -£30,520,000 | |
| Profit before tax | -£28,512,000 | -£34,311,000 | |
| Net profit | -£25,810,000 | -£32,311,000 | |
| Cash | £1,573,000 | £3,151,000 | |
| Total assets less current liabilities | — | — | |
| Net assets | -£129,627,000 | -£161,453,000 | |
| Equity | -£129,627,000 | -£161,453,000 | |
| Average employees | 151 | 139 | |
| Wages | £9,168,000 | £8,561,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | -836.7% | -2063.6% | |
| Net margin | -858.9% | -2184.7% | |
| Gearing (liabilities / total assets) | 729.3% | 954.6% | |
| Current ratio | 4.87x | 6.24x | |
| Interest cover | -6.58x | -6.35x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Notwithstanding net liabilities of £161.5m and a reported total comprehensive loss of £32.3m for the year ended 31 December 2024, the financial statements have been prepared on a going concern basis which the directors believe to be appropriate. The Company has received a letter of support from Creo Medical Group Plc to meet its liabilities.”
Group structure
- CREO MEDICAL LIMITED · parent
- Creo Medical, Inc. 100%
- Creo Medical Innovations Limited 100%
- Creo Medical Ireland Limited 100%
- Creo Medical PTE Limited 100%
- Aber Electronics Limited 100%
Significant events
- “On 19 March 2025 Aber Electronics Limited ("Aber"), a wholly owned subsidiary of Creo Medical Limited, was sold by Creo Medical Limited to its management.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 14 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CRAVEN, Richard Gary | Secretary | 2024-07-01 | — | — |
| GULLIFORD, Craig Jonathan | Director | 2012-03-30 | May 1970 | British |
| HANCOCK, Christopher Paul, Prof | Director | 2003-02-20 | Mar 1967 | British |
| REES, Richard John | Director | 2016-07-01 | May 1976 | Welsh |
Show 14 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FROST, Kate | Secretary | 2014-08-12 | 2016-07-01 |
| HANCOCK, Christopher Paul, Dr | Secretary | 2003-02-20 | 2007-03-06 |
| REES, Richard | Secretary | 2016-07-01 | 2024-07-01 |
| SWIFT, Derek Alan | Secretary | 2007-03-06 | 2014-08-12 |
| DUPORT SECRETARY LIMITED | Corporate Nominee Secretary | 2003-02-06 | 2003-02-07 |
| CARTMELL, Simon Christopher | Director | 2014-10-23 | 2016-12-09 |
| CHAUDHRY, Mohammed Sabih, Doctor | Director | 2003-02-20 | 2007-03-06 |
| FARMER, Mark | Director | 2014-10-23 | 2016-12-09 |
| HALES, Philip William, Dr | Director | 2008-11-01 | 2010-02-08 |
| JACKSON, Mark Bentley | Director | 2009-07-22 | 2016-12-09 |
| MORRIS, Steven | Director | 2009-01-05 | 2019-02-25 |
| SPICER, Charles Alexander Evan, Dr | Director | 2016-07-01 | 2017-08-25 |
| WOODS, David Gerard | Director | 2015-09-10 | 2017-08-25 |
| DUPORT DIRECTOR LIMITED | Corporate Director | 2003-02-06 | 2003-02-07 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Creo Medical Group Plc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-12-09 | Active |
| Mr Richard John Rees | Individual | Significant influence, significant-influence-or-control-as-firm | 2016-07-01 | Ceased 2016-11-09 |
| Mr Craig Jonathan Gulliford | Individual | Significant influence, significant-influence-or-control-as-firm | 2016-04-06 | Ceased 2016-11-09 |
| Dr Christopher Paul Hancock | Individual | Significant influence, significant-influence-or-control-as-firm | 2016-04-06 | Ceased 2016-11-09 |
| Mr Steven Morris | Individual | Significant influence, significant-influence-or-control-as-firm | 2016-04-06 | Ceased 2016-11-09 |
Filing timeline
Last 20 of 144 total filings
Material constitutional events — rename, articles re-file, resolution
- 2021-11-02 MA Memorandum articles
- 2021-11-02 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-10-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-21 | AA | accounts | Accounts with accounts type full | |
| 2024-11-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-02 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-07-02 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-06-24 | AA | accounts | Accounts with accounts type full | |
| 2023-11-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-05 | AA | accounts | Accounts with accounts type full | |
| 2023-04-19 | AD02 | address | Change sail address company with old address new address | |
| 2022-11-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-06-21 | AA | accounts | Accounts with accounts type full | |
| 2021-11-24 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-11-24 | AD03 | address | Move registers to sail company with new address | |
| 2021-11-24 | AD02 | address | Change sail address company with new address | |
| 2021-11-02 | SH08 | capital | Capital name of class of shares | |
| 2021-11-02 | MA | incorporation | Memorandum articles | |
| 2021-11-02 | RESOLUTIONS | resolution | Resolution | |
| 2021-08-10 | AA | accounts | Accounts with accounts type full | |
| 2020-11-24 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2020-11-24 | SH01 | capital | Capital allotment shares |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-50.8%
£3,005,000 £1,479,000
-
Cash
+100.3%
£1,573,000 £3,151,000
-
Net assets
-24.6%
-£129,627,000 -£161,453,000
-
Employees
-7.9%
151 139
-
Operating profit
-21.4%
-£25,142,000 -£30,520,000
-
Profit before tax
-20.3%
-£28,512,000 -£34,311,000
-
Wages
-6.6%
£9,168,000 £8,561,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers